GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.

When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

A WOMAN has revealed that she has shed 7kg without the help of Mounjaro. Since becoming available on the NHS earlier this ...

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the Company's senior executives for ...

People on weight-loss drugs often lose muscle mass while they lose weight, but new scientific findings suggest boosting your ...

LinkGevity is among a cluster of biotech firms in Cambridge working on potential longevity treatments. They include clock.bio ...

The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?

The illicit supply of unregulated weight loss drugs is becoming an ‘emerging concern’ for Police Scotland and the.

People are injecting peptides to build muscle, trim fat, and reduce inflammation. Does it work?